About Alpha-N-acetylgalactosaminidase deficiency type 3
Alpha-N-acetylgalactosaminidase deficiency type 3 is a rare disease catalogued by Orphanet (ORPHA:79281). It is associated with the NAGA gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Alpha-N-acetylgalactosaminidase deficiency type 3 trials.
Search ClinicalTrials.gov for "Alpha-N-acetylgalactosaminidase deficiency type 3" or filter by Orphanet code ORPHA:79281 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Alpha-N-acetylgalactosaminidase deficiency type 3 trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Alpha-N-acetylgalactosaminidase deficiency type 3. Updated daily.